T2-High Endotype and Response to Biological Treatments in Patients with <i>Bronchiectasis</i>

T2-High Endotype and Response to Biological Treatments in Patients with <i>Bronchiectasis</i>

Although bronchiectasis pathophysiology has been historically understood around the presence of airway neutrophilic inflammation, recent experiences are consistent with the identification of a type 2 inflammation (T2) high endotype in bronchiectasis. In order to evaluate prevalence and clinical char...

Full description

Bibliographic Details
Main Authors: Martina Oriano, Andrea Gramegna, Francesco Amati, Alice D’Adda, Michele Gaffuri, Marco Contoli, Francesco Bindo, Edoardo Simonetta, Carlotta Di Francesco, Martina Santambrogio, Giovanni Sotgiu, Francesco Blasi, Stefano Aliberti
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomedicines
Subjects:
Bronchiectasis
T2-high
type 2 inflammation
eosinophilia
Online Access:https://www.mdpi.com/2227-9059/9/7/772

Internet

https://www.mdpi.com/2227-9059/9/7/772

Similar Items